Drug Abuse News and Research

RSS

UC San Diego receives $8 million grant to study the genetics of substance use disorder

University of California San Diego School of Medicine has received a five-year, $8 million grant from the National Institute on Drug Abuse (NIDA) to study the genetics of substance use disorders.

28 Oct 2024

New NIH grants support research on infant development with innovative technology

Infant sleep patterns and emotional regulation are important for healthy development, but it is challenging to get real-time insights into infant behavior.

24 Oct 2024

Methadone more effective than buprenorphine in reducing treatment discontinuation

People with opioid use disorder in British Columbia who received methadone had a 37–40 per cent lower rate of treatment discontinuation compared with those who received buprenorphine/naloxone.

21 Oct 2024

Expanded treatment options linked to 37% reduction in drug overdose deaths

Expanded treatment options, increased naloxone distribution and targeted education campaigns likely led to a 37% reduction in overdose deaths from opioids combined with stimulant drugs other than cocaine, according to the results of a large federally funded study.

21 Oct 2024

University of Michigan receives grant to study pain management in opioid use disorder

The University of Michigan will use a new $3.6 million federal grant to study how pain and opioids after surgery impact people with opioid use disorder, how guidelines might be adjusted to address post-surgical pain and how to prevent opioid-related harms.

12 Oct 2024

New research explores how campus belonging impacts binge drinking and substance use

Students who feel a sense of belonging at their university are more likely to binge drink than those who do not feel the same connection, according to a new study by researchers at Penn State, the University of California, Santa Cruz and University of Oregon.

12 Oct 2024

Integrated HIV prevention strategy increases PrEP adherence among transgender women

Researchers from the HIV Prevention Trials Network (HPTN) presented results from HPTN 091 ("I Am Study") at the HIVR4P 2024 conference in Lima, Peru. The study examined the acceptability and feasibility of an integrated multicomponent strategy to enhance daily oral HIV pre-exposure prophylaxis (PrEP) uptake and adherence among transgender women in a randomized immediate versus deferred design.

12 Oct 2024

First map of DNA modification in the hippocampus and prefrontal cortex created

A UCLA-led study has provided an unprecedented look at how gene regulation evolves during human brain development, showing how the 3D structure of chromatin - DNA and proteins - plays a critical role.

9 Oct 2024

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Since being deemed a public health emergency in 2017, opioids are responsible for 72% of drug overdose deaths in the United States, according to the National Center for Drug Abuse Statistics.

25 Sep 2024

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Adults with opioid use disorder who receive a higher daily dose of the opioid addiction treatment medication buprenorphine may have a lower risk of subsequent emergency department visits or use of inpatient services related to behavioral health (such as for mental health and substance use disorders) than adults receiving the recommended dose, according to an analysis funded by the National Institutes of Health (NIH).

25 Sep 2024

Study reveals limited access to opioid treatment in US jails

A new look into addiction treatment availability in the U.S. criminal justice system reveals that fewer than half (43.8%) of 1,028 jails surveyed across the nation offered any form of medication for opioid use disorder, and only 12.8% made these available to anyone with the disorder.

24 Sep 2024

New online platform aims to empower Latino families in mental health and behavior

Cory Cobb, PhD, an assistant professor of health behavior at the Texas A&M University School of Public Health, is leading a research team that has been awarded a three-year grant from the National Institute of Mental Health to create an online platform for the intervention program they developed for United States-based Spanish-speaking Latino parents and their children.

20 Sep 2024

Telehealth app found to improve retention rates in opioid use disorder treatment

Patients who initiated treatment for opioid use disorder through a telehealth mobile app stayed with treatment at a greater rate over six months than those who started treatment in a physical clinic, a new study led by Oregon Health & Science University found.

17 Sep 2024

Study links COVID-19 to higher benzodiazepine use in postpartum women

New research from the University of Georgia suggests the COVID-19 pandemic may have had an unexpected side effect for postpartum women: more benzodiazepine prescriptions.

13 Sep 2024

Study points to fentanyl as key factor in Oregon overdose spike

When overdose rates spiked in Oregon in 2021 after the state decriminalized low-level drug possession, blame quickly turned to the new state law.

5 Sep 2024

Cannabis use linked to poorer sleep and memory problems

The growing legal use of recreational and medical cannabis has generated an increased concern for potential side effects from long-term use, particularly regarding problems with memory and sleep.

5 Sep 2024

APDI provides $200,000 in grants to advance pediatric substance use disorder devices

The Alliance for Pediatric Device Innovation (APDI), a nonprofit consortium led by Children's National Hospital and funded through the Food and Drug Administration (FDA), announces today the recipients of grants totaling $200,000 to advance pediatric medical devices that improve the monitoring, diagnosis or treatment of youth suffering from substance use disorder and addiction.

4 Sep 2024

Addressing the gender gap in substance abuse treatment

Woman with opioid use disorder and who are also involved with the criminal legal system face unique challenges and stigmas that may keep them from seeking substance use treatment and harm reduction tools that could prevent overdose deaths, according to new research led by a team from Penn State.

28 Aug 2024

NIH funds study on psychedelics' potential to treat methamphetamine addiction

John McCorvy, PhD, Assistant Professor in the Department of Cell Biology, Neurobiology, and Anatomy at the Medical College of Wisconsin (MCW); Adam Halberstadt, PhD, Professor of Psychiatry at the University of California San Diego (UCSD) and Director of the UCSD Center for Psychedelic Research; and Kevin Murnane, PhD, Associate Professor of Pharmacology, Toxicology, and Neuroscience and Director of Basic Science Research for the Louisiana Addiction Research Center at LSU Health Shreveport, were recently awarded a five-year, $2.4 million research grant from the National Institute on Drug Abuse (NIDA), part of the National Institutes of Health (NIH), to uncover critical insights into how psychedelics could be used as a therapeutic to treat methamphetamine addiction.

27 Aug 2024

Exploring the impact of xylazine on wound care needs

The animal tranquilizer xylazine is increasingly found in the illicit opioid supply nationwide, leading to severe wounds among people who use drugs. New research led by a University of Pittsburgh physician-scientist and published in Drug and Alcohol Dependence seeks to understand the wound care experiences of this population.

22 Aug 2024

Drug Abuse News and Research

UC San Diego receives $8 million grant to study the genetics of substance use disorder

New NIH grants support research on infant development with innovative technology

Methadone more effective than buprenorphine in reducing treatment discontinuation

Expanded treatment options linked to 37% reduction in drug overdose deaths

University of Michigan receives grant to study pain management in opioid use disorder

New research explores how campus belonging impacts binge drinking and substance use

Integrated HIV prevention strategy increases PrEP adherence among transgender women

First map of DNA modification in the hippocampus and prefrontal cortex created

Study links semaglutide to reduced opioid overdose risk in patients with OUD and diabetes

Higher doses of buprenorphine linked to lower emergency visits in opioid use disorder

Study reveals limited access to opioid treatment in US jails

New online platform aims to empower Latino families in mental health and behavior

Telehealth app found to improve retention rates in opioid use disorder treatment

Study links COVID-19 to higher benzodiazepine use in postpartum women

Study points to fentanyl as key factor in Oregon overdose spike

Cannabis use linked to poorer sleep and memory problems

APDI provides $200,000 in grants to advance pediatric substance use disorder devices

Addressing the gender gap in substance abuse treatment

NIH funds study on psychedelics' potential to treat methamphetamine addiction

Exploring the impact of xylazine on wound care needs

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News